SMG1 and plasma cell myeloma: CC‐115 treatment showed a dose‐dependent increase of NMD transcripts, unfolded protein response (UPR) transcripts, and cell death via SMG1 inhibition in a subset of cell lines, primary multiple myeloma cells, and xenograft mouse models.